Nestlé’s $2.6 Billion Acquisition of Aimmune Therapeutics

Mayer Brown advised Nestlé Health Science, while Davis Polk advised JP Morgan Securities LLC and Lazard as financial advisers to Aimmune Therapeutics in connection with the…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Author: Ambrogio Visconti

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here